Brief CBT for Patients Undergoing TAVR
Primary Purpose
Depression, Anxiety
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Brief Bedside CBT
Sponsored by

About this trial
This is an interventional prevention trial for Depression, Anxiety focused on measuring CBT, Brief Therapy, Bedside Intervention
Eligibility Criteria
Inclusion Criteria:
- Adults 18 years of age and older
- Voluntary participation
- Informed consent obtained
- Patients with severe aortic stenosis and high surgical risk who are undergoing TAVR
Exclusion Criteria:
- Current psychiatric instability (eg., suicidality, schizophrenia, bipolar disorder, active alcoholism or substance abuse)
- Severe cognitive impairment, i.e. dementia
- Life threatening co-morbidities
- Inability to provide consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Brief Bedside CBT
Treatment As Usual
Arm Description
Outcomes
Primary Outcome Measures
Change from Baseline Score on Beck Depression Inventory II (BDI-II)
21-item self-report questionnaire with good reliability and validity in assessing symptoms of depression. Total score range 0-63 with higher scores indicating a worse outcome. Total BDI-II scores are interpreted as follows, 0-13: minimal, 14-19: mild, 20-28: moderate, 29-63: severe. In this study, a score of 14 or greater, and 20 or greater, were used define subpopulations with significant symptoms of depression on the BDI-II.
Secondary Outcome Measures
Change from Baseline Score on State Trait Anxiety Inventory Form YI (STAI-YI)
20-item self-report questionnaire with good internal consistency and construct validity in assessing symptoms of anxiety. Total score range 20-80 with higher scores indicating a worse outcome. The recommended cutoff score for clinically significant anxiety is 39 but a recent validity study of anxiety disorders in cardiac patients found ≥ 40 as an optimal cutoff score for screening the presence of an anxiety disorder. In this study, a score of 40 or greater, and 46 or greater, were used to define subpopulations with significant symptoms of anxiety on the STAI-Y1.
Change from Baseline Score on Minnesota Living With Heart Failure Questionnaire (MLHFQ)
21-item self-report questionnaire designed to measure the effects of heart failure and treatments for heart failure on and individual's quality of life. Total score range 0-105. The total score is considered a measurement of heart failure severity as indicated by its adverse effect on the respondent's life over the past month. In this study, the MLHFQ total score was used as a continuous measure of heart failure related quality of life. Higher scores indicate a worse outcome.
Change from Baseline Score on 12-Item Short Form Health Survey (SF12v2)
An abbreviated version of the 36-item Short Form Health Survey, which is a well-established measure assessing dimensions of mental and physical health. In this study, PCS and MCS summary scores were used as continuous measures of health-related quality of life. Scoring procedures involve computer-based scoring algorithms to calculate two summary scores, the physical component summary score (PCS) and mental component summary score (MCS), on a scale from 0 to 100 with a mean of 50 ± 10 that is normally distributed according to the adult U.S. population. Higher scores indicate a better outcome.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03798548
Brief Title
Brief CBT for Patients Undergoing TAVR
Official Title
Brief Cognitive Behavioral Therapy for Patients Undergoing Transcatheter Aortic Valve Replacement: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
January 15, 2015 (Actual)
Primary Completion Date
March 31, 2017 (Actual)
Study Completion Date
May 15, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Adult patients scheduled to undergo TAVR were randomized to receive brief bedside cognitive behavioral therapy for depression/anxiety or treatment as usual.
Detailed Description
Depression and anxiety are common symptoms in patients undergoing cardiac surgery and associated with increased cardiac morbidity and decreased functional status. Cognitive behavioral therapy (CBT) has been shown to be an effective intervention to treat these symptoms after cardiac surgery, but has not yet been studied in patients undergoing less invasive cardiac procedures such as Transcatheter Aortic Valve Replacement (TAVR). This study will examine the effect of CBT on symptoms of anxiety and depression in patients undergoing TAVR.
The CBT protocol was loosely structured on the Managing Depression and Anxiety using Education and Skills (MADES) protocol described in Dao and colleagues (2011). The current intervention was designed to address the needs of individuals who may develop anxiety or depression symptoms post-TAVR. The CBT intervention consisted of four 30 to 60-minute bedside treatment sessions with a trained clinician while the participant was hospitalized for TAVR.
Main outcome measures were self-reported symptoms of depression and anxiety as measured by the Beck Depression Inventory-II and State Trait Anxiety Inventory Form Y1. Secondary outcomes included health related quality of life and hospital length of stay.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Anxiety
Keywords
CBT, Brief Therapy, Bedside Intervention
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Brief Bedside CBT versus Treatment As Usual
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
146 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Brief Bedside CBT
Arm Type
Experimental
Arm Title
Treatment As Usual
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Brief Bedside CBT
Intervention Description
4 sessions of CBT including psychoeducation about TAVR and how mood can impact recovery in cardiac patients, discussion of patients' expectations and any concerns. Teaching and practice of cognitive restructuring and behavioral goal setting techniques for a healthy recovery.
Primary Outcome Measure Information:
Title
Change from Baseline Score on Beck Depression Inventory II (BDI-II)
Description
21-item self-report questionnaire with good reliability and validity in assessing symptoms of depression. Total score range 0-63 with higher scores indicating a worse outcome. Total BDI-II scores are interpreted as follows, 0-13: minimal, 14-19: mild, 20-28: moderate, 29-63: severe. In this study, a score of 14 or greater, and 20 or greater, were used define subpopulations with significant symptoms of depression on the BDI-II.
Time Frame
An average of 3 days post TAVR Procedure, 1-Month Follow Up
Secondary Outcome Measure Information:
Title
Change from Baseline Score on State Trait Anxiety Inventory Form YI (STAI-YI)
Description
20-item self-report questionnaire with good internal consistency and construct validity in assessing symptoms of anxiety. Total score range 20-80 with higher scores indicating a worse outcome. The recommended cutoff score for clinically significant anxiety is 39 but a recent validity study of anxiety disorders in cardiac patients found ≥ 40 as an optimal cutoff score for screening the presence of an anxiety disorder. In this study, a score of 40 or greater, and 46 or greater, were used to define subpopulations with significant symptoms of anxiety on the STAI-Y1.
Time Frame
An average of 3 days post TAVR Procedure, 1-Month Follow Up
Title
Change from Baseline Score on Minnesota Living With Heart Failure Questionnaire (MLHFQ)
Description
21-item self-report questionnaire designed to measure the effects of heart failure and treatments for heart failure on and individual's quality of life. Total score range 0-105. The total score is considered a measurement of heart failure severity as indicated by its adverse effect on the respondent's life over the past month. In this study, the MLHFQ total score was used as a continuous measure of heart failure related quality of life. Higher scores indicate a worse outcome.
Time Frame
1-Month Follow Up
Title
Change from Baseline Score on 12-Item Short Form Health Survey (SF12v2)
Description
An abbreviated version of the 36-item Short Form Health Survey, which is a well-established measure assessing dimensions of mental and physical health. In this study, PCS and MCS summary scores were used as continuous measures of health-related quality of life. Scoring procedures involve computer-based scoring algorithms to calculate two summary scores, the physical component summary score (PCS) and mental component summary score (MCS), on a scale from 0 to 100 with a mean of 50 ± 10 that is normally distributed according to the adult U.S. population. Higher scores indicate a better outcome.
Time Frame
1-Month Follow Up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults 18 years of age and older
Voluntary participation
Informed consent obtained
Patients with severe aortic stenosis and high surgical risk who are undergoing TAVR
Exclusion Criteria:
Current psychiatric instability (eg., suicidality, schizophrenia, bipolar disorder, active alcoholism or substance abuse)
Severe cognitive impairment, i.e. dementia
Life threatening co-morbidities
Inability to provide consent
12. IPD Sharing Statement
Citations:
PubMed Identifier
21621227
Citation
Dao TK, Youssef NA, Armsworth M, Wear E, Papathopoulos KN, Gopaldas R. Randomized controlled trial of brief cognitive behavioral intervention for depression and anxiety symptoms preoperatively in patients undergoing coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2011 Sep;142(3):e109-15. doi: 10.1016/j.jtcvs.2011.02.046. Epub 2011 May 28.
Results Reference
background
Links:
URL
https://www.jtcvs.org/article/S0022-5223(11)00402-8/fulltext
Description
Link to Dao et al 2011
Learn more about this trial
Brief CBT for Patients Undergoing TAVR
We'll reach out to this number within 24 hrs